Response to inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis and chronic bronchial infection unrelated to Pseudomonas aeruginosa

INTRODUCTION: Inhaled antibiotics reduce the frequency of exacerbations. The objective was to assess the efficacy of inhaled ceftazidime in patients with non‐cystic fibrosis bronchiectasis (NCFB) and concomitant chronic bronchial infection (CBI) caused by potentially pathogenic microorganisms (PPM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Riveiro, Vanessa, Casal, Ana, Álvarez‐Dobaño, José M., Lourido, Tamara, Suárez‐Artime, Pedro, Rodríguez‐García, Carlota, Ferreiro, Lucía, Toubes, María E., Valdés, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629990/
https://www.ncbi.nlm.nih.gov/pubmed/36017771
http://dx.doi.org/10.1111/crj.13534

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629990/
https://www.ncbi.nlm.nih.gov/pubmed/36017771
http://dx.doi.org/10.1111/crj.13534

Ejemplares similares